论文部分内容阅读
贵州瑞和制药有限公司创立于1998年,是一家集中西药研发、生产、销售为一体的现代化高新技术企业,总投资规模5000余万元。公司目前拥有独家知识产权、用于治疗前列腺增生和慢性前列腺炎的纯中药注射剂“川参通注射液”;它是国家药品标准中指定用于前列腺局部注射的中药制剂,是科技含量高、又极具市场发展潜力的国家“中药二类新药”。临床应用所体现的操
Founded in 1998, Guizhou Ruihe Pharmaceutical Co., Ltd. is a modern high-tech enterprise focused on R&D, production and sales of Western medicine, with a total investment of over 50 million yuan. The company currently has exclusive intellectual property rights for the treatment of benign prostatic hyperplasia and chronic prostatitis of pure Chinese medicine injection “Chuan Shen Tong injection”; it is the national drug standard designated for the local injection of prostate preparations, is a high technological content, and Countries with great potential for market development “Chinese medicines for new drugs”. The clinical application of the exercise